Literature DB >> 21956113

Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein.

Natasha Case1, Jacob Thomas, Buer Sen, Maya Styner, Zhihui Xie, Kornelia Galior, Janet Rubin.   

Abstract

Mechanical signals can inactivate glycogen synthase kinase 3β (GSK3β), resulting in stabilization of β-catenin. This signaling cascade is necessary for the inhibition of adipogenesis in mesenchymal stem cells (MSC) that is produced by a daily strain regimen. We investigated whether Akt is the mechanically activated kinase responsible for phosphorylation and inactivation of GSK3β in MSC. Mechanical strain (2% magnitude, 0.17 Hz) induced phosphorylation of Akt at Ser-473 and Thr-308 in parallel with phosphorylation of GSK3β at Ser-9. Inhibiting Akt (Akt1/2 kinase inhibitor treatment or Akt knockdown) prevented strain-induced phosphorylation of GSK3β at Ser-9. Inhibition of PI3K prevented Thr-308 phosphorylation, but strain-induced Ser-473 phosphorylation was measurable and induced phosphorylation of GSK3β, suggesting that Ser-473 phosphorylation is sufficient for the downstream mechanoresponse. As Rictor/mTORC2 (mammalian target of rapamycin complex 2) is known to transduce phosphorylation of Akt at Ser-473 by insulin, we investigated whether it contributes to strain-induced Ser-473 phosphorylation. Phosphorylation of Ser-473 by both mechanical and insulin treatment in MSC was prevented by the mTOR inhibitor KU0063794. When mTORC2 was blocked, mechanical GSK3β inactivation was prevented, whereas insulin inhibition of GSK3β was still measured in the absence of Ser-473 phosphorylation, presumably through phosphorylation of Akt at Thr-308. In sum, mechanical input initiates a signaling cascade that is uniquely dependent on mTORC2 activation and phosphorylation of Akt at Ser-473, an effect sufficient to cause inactivation of GSK3β. Thus, mechanical regulation of GSK3β downstream of Akt is dependent on phosphorylation of Akt at Ser-473 in a manner distinct from that of growth factors. As such, Akt reveals itself to be a pleiotropic signaling molecule whose downstream targets are differentially regulated depending upon the nature of the activating input.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956113      PMCID: PMC3234768          DOI: 10.1074/jbc.M111.265330

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

Authors:  Sanford R Sampson; Denise R Cooper
Journal:  Mol Genet Metab       Date:  2006-06-23       Impact factor: 4.797

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

Review 3.  Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.

Authors:  Kathryn G Foster; Diane C Fingar
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo.

Authors:  Daniel G Sedding; Jennifer Hermsen; Ulrike Seay; Oliver Eickelberg; Wolfgang Kummer; Carsten Schwencke; Ruth H Strasser; Harald Tillmanns; Ruediger C Braun-Dullaeus
Journal:  Circ Res       Date:  2005-02-24       Impact factor: 17.367

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation.

Authors:  Edward J McManus; Barry J Collins; Peter R Ashby; Alan R Prescott; Victoria Murray-Tait; Laura J Armit; J Simon C Arthur; Dario R Alessi
Journal:  EMBO J       Date:  2004-04-29       Impact factor: 11.598

7.  Developmentally spliced PKCbetaII provides a possible link between mTORC2 and Akt kinase to regulate 3T3-L1 adipocyte insulin-stimulated glucose transport.

Authors:  E Kleiman; G Carter; T Ghansah; N A Patel; D R Cooper
Journal:  Biochem Biophys Res Commun       Date:  2009-08-15       Impact factor: 3.575

Review 8.  The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!

Authors:  Sara A Wickström; Anika Lange; Eloi Montanez; Reinhard Fässler
Journal:  EMBO J       Date:  2009-12-24       Impact factor: 11.598

9.  Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).

Authors:  Juan M García-Martínez; Jennifer Moran; Rosemary G Clarke; Alex Gray; Sabina C Cosulich; Christine M Chresta; Dario R Alessi
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

10.  Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha.

Authors:  Victoria J Armstrong; Mariusz Muzylak; Andrew Sunters; Gul Zaman; Leanne K Saxon; Joanna S Price; Lance E Lanyon
Journal:  J Biol Chem       Date:  2007-05-08       Impact factor: 5.157

View more
  37 in total

1.  Understanding Mechanobiology: Physical Therapists as a Force in Mechanotherapy and Musculoskeletal Regenerative Rehabilitation.

Authors:  William R Thompson; Alexander Scott; M Terry Loghmani; Samuel R Ward; Stuart J Warden
Journal:  Phys Ther       Date:  2015-12-04

2.  In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism.

Authors:  N Lara-Castillo; N A Kim-Weroha; M A Kamel; B Javaheri; D L Ellies; R E Krumlauf; G Thiagarajan; M L Johnson
Journal:  Bone       Date:  2015-03-30       Impact factor: 4.398

3.  Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells.

Authors:  William R Thompson; Christophe Guilluy; Zhihui Xie; Buer Sen; Kaitlyn E Brobst; Sherwin S Yen; Gunes Uzer; Maya Styner; Natasha Case; Keith Burridge; Janet Rubin
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

4.  Insulin effects on glucose tolerance, hypermetabolic response, and circadian-metabolic protein expression in a rat burn and disuse model.

Authors:  Heather F Pidcoke; Lisa A Baer; Xiaowu Wu; Steven E Wolf; James K Aden; Charles E Wade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

Review 5.  Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity.

Authors:  Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2019-06       Impact factor: 43.330

6.  Actin up in the Nucleus: Regulation of Actin Structures Modulates Mesenchymal Stem Cell Differentiation.

Authors:  Janet Rubin; Buer Sen
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

7.  TPPU protects tau from H2O2-induced hyperphosphorylation in HEK293/tau cells by regulating PI3K/AKT/GSK-3β pathway.

Authors:  En-Sheng Yao; Yan Tang; Xing-Hua Liu; Ming-Huan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

8.  LARG GEF and ARHGAP18 orchestrate RhoA activity to control mesenchymal stem cell lineage.

Authors:  William R Thompson; Sherwin S Yen; Gunes Uzer; Zhihui Xie; Buer Sen; Maya Styner; Keith Burridge; Janet Rubin
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

Review 9.  Concise Review: Plasma and Nuclear Membranes Convey Mechanical Information to Regulate Mesenchymal Stem Cell Lineage.

Authors:  Gunes Uzer; Robyn K Fuchs; Janet Rubin; William R Thompson
Journal:  Stem Cells       Date:  2016-03-14       Impact factor: 6.277

10.  mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells.

Authors:  Buer Sen; Zhihui Xie; Natasha Case; William R Thompson; Gunes Uzer; Maya Styner; Janet Rubin
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.